Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse

Akihiro Mouri, Hirotake Hida, Yukihiro Noda

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Abuse of phencyclidine (PCP), a noncompetitive N-methyl-. d-aspartate receptor antagonist, induces schizophrenia-like psychosis in humans. In addition, emotional and cognitive behavioral impairments, or glutamatergic-based dysfunction, have been noted following subchronic PCP administration to adult and perinatal rodents. Such impairments have also been noted following a combination of immune activation by polyriboinosinic-polyribocytidylic acid (Poly I:C) administered to neonatal rodents and by subchronic PCP administration to adolescent rodents. These impairments are associated with increased glial cell expression of the glial glutamate and aspartate transporter. Facilitation of glutamatergic neurotransmission by intracerebral microinjection of glutamate transporter inhibitor ameliorated the behavioral impairments in mice that had received subchronic PCP or a combination of Poly I:C and PCP. Given the clinical similarity between PCP psychosis and schizophrenia, and the findings described here, this approach may provide a useful animal model for studying the neuropathology of PCP psychosis or schizophrenia, and the usefulness of glutamate transporter inhibitors as potential therapeutic targets.

Original languageEnglish
Title of host publicationStimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects
PublisherElsevier Inc.
Pages625-635
Number of pages11
Volume2
ISBN (Electronic)9780128003756
ISBN (Print)9780128002124
DOIs
Publication statusPublished - 15-04-2016
Externally publishedYes

Fingerprint

Phencyclidine Abuse
Amino Acid Transport System X-AG
Psychotic Disorders
Rodentia
Schizophrenia
Neuroglia
Microinjections
Synaptic Transmission
Animal Models
Acids
Neuropathology

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Mouri, A., Hida, H., & Noda, Y. (2016). Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse. In Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects (Vol. 2, pp. 625-635). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800212-4.00058-3
Mouri, Akihiro ; Hida, Hirotake ; Noda, Yukihiro. / Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse. Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2 Elsevier Inc., 2016. pp. 625-635
@inbook{4256d4c81e2d4806b62dc651bf86ccdb,
title = "Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse",
abstract = "Abuse of phencyclidine (PCP), a noncompetitive N-methyl-. d-aspartate receptor antagonist, induces schizophrenia-like psychosis in humans. In addition, emotional and cognitive behavioral impairments, or glutamatergic-based dysfunction, have been noted following subchronic PCP administration to adult and perinatal rodents. Such impairments have also been noted following a combination of immune activation by polyriboinosinic-polyribocytidylic acid (Poly I:C) administered to neonatal rodents and by subchronic PCP administration to adolescent rodents. These impairments are associated with increased glial cell expression of the glial glutamate and aspartate transporter. Facilitation of glutamatergic neurotransmission by intracerebral microinjection of glutamate transporter inhibitor ameliorated the behavioral impairments in mice that had received subchronic PCP or a combination of Poly I:C and PCP. Given the clinical similarity between PCP psychosis and schizophrenia, and the findings described here, this approach may provide a useful animal model for studying the neuropathology of PCP psychosis or schizophrenia, and the usefulness of glutamate transporter inhibitors as potential therapeutic targets.",
author = "Akihiro Mouri and Hirotake Hida and Yukihiro Noda",
year = "2016",
month = "4",
day = "15",
doi = "10.1016/B978-0-12-800212-4.00058-3",
language = "English",
isbn = "9780128002124",
volume = "2",
pages = "625--635",
booktitle = "Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects",
publisher = "Elsevier Inc.",
address = "United States",

}

Mouri, A, Hida, H & Noda, Y 2016, Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse. in Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. vol. 2, Elsevier Inc., pp. 625-635. https://doi.org/10.1016/B978-0-12-800212-4.00058-3

Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse. / Mouri, Akihiro; Hida, Hirotake; Noda, Yukihiro.

Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2 Elsevier Inc., 2016. p. 625-635.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse

AU - Mouri, Akihiro

AU - Hida, Hirotake

AU - Noda, Yukihiro

PY - 2016/4/15

Y1 - 2016/4/15

N2 - Abuse of phencyclidine (PCP), a noncompetitive N-methyl-. d-aspartate receptor antagonist, induces schizophrenia-like psychosis in humans. In addition, emotional and cognitive behavioral impairments, or glutamatergic-based dysfunction, have been noted following subchronic PCP administration to adult and perinatal rodents. Such impairments have also been noted following a combination of immune activation by polyriboinosinic-polyribocytidylic acid (Poly I:C) administered to neonatal rodents and by subchronic PCP administration to adolescent rodents. These impairments are associated with increased glial cell expression of the glial glutamate and aspartate transporter. Facilitation of glutamatergic neurotransmission by intracerebral microinjection of glutamate transporter inhibitor ameliorated the behavioral impairments in mice that had received subchronic PCP or a combination of Poly I:C and PCP. Given the clinical similarity between PCP psychosis and schizophrenia, and the findings described here, this approach may provide a useful animal model for studying the neuropathology of PCP psychosis or schizophrenia, and the usefulness of glutamate transporter inhibitors as potential therapeutic targets.

AB - Abuse of phencyclidine (PCP), a noncompetitive N-methyl-. d-aspartate receptor antagonist, induces schizophrenia-like psychosis in humans. In addition, emotional and cognitive behavioral impairments, or glutamatergic-based dysfunction, have been noted following subchronic PCP administration to adult and perinatal rodents. Such impairments have also been noted following a combination of immune activation by polyriboinosinic-polyribocytidylic acid (Poly I:C) administered to neonatal rodents and by subchronic PCP administration to adolescent rodents. These impairments are associated with increased glial cell expression of the glial glutamate and aspartate transporter. Facilitation of glutamatergic neurotransmission by intracerebral microinjection of glutamate transporter inhibitor ameliorated the behavioral impairments in mice that had received subchronic PCP or a combination of Poly I:C and PCP. Given the clinical similarity between PCP psychosis and schizophrenia, and the findings described here, this approach may provide a useful animal model for studying the neuropathology of PCP psychosis or schizophrenia, and the usefulness of glutamate transporter inhibitors as potential therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84969731105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969731105&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800212-4.00058-3

DO - 10.1016/B978-0-12-800212-4.00058-3

M3 - Chapter

AN - SCOPUS:84969731105

SN - 9780128002124

VL - 2

SP - 625

EP - 635

BT - Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects

PB - Elsevier Inc.

ER -

Mouri A, Hida H, Noda Y. Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse. In Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants and International Aspects. Vol. 2. Elsevier Inc. 2016. p. 625-635 https://doi.org/10.1016/B978-0-12-800212-4.00058-3